Lingohr Asset Management’s AbbVie ABBV Stock Holding History

Lingohr Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$644K	Buy	2,800 +449	+19%	+$91.4K	1.12%	36
2025 Q2	$436K	Sell	2,351 -22,504	-91%	-$4.18M	0.79%	51
2025 Q1	$5.16M	Buy	24,855 +19,783	+390%	+$3.85M	1.29%	34
2024 Q4	$885K	Buy	+5,072	New	+$933K	1.83%	17
2020 Q1	–	Sell	-13,000	Closed	-$1.15M	–	68
2019 Q4	$1.15M	Buy	13,000 +5,900	+83%	+$490K	1.11%	17
2019 Q3	$538K	Hold	7,100	–	–	0.54%	90
2019 Q2	$516K	Buy	+7,100	New	+$558K	0.51%	93

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lingohr Asset Management's ABBV Position: Q3 2025 in Review

Lingohr Asset Management increased its AbbVie (ABBV) stake by 19% in Q3 2025, buying an estimated $91.4K and bringing the position to 2,800 shares worth $644K. The position accounts for 1.12% of the portfolio, ranked #36.

Lingohr Asset Management first reported a position in ABBV in Q2 2019 and has held it in 7 quarters since. The position peaked at $5.16M in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Lingohr Asset Management held 2,800 shares of AbbVie worth $644K as of Q3 2025.
Lingohr Asset Management bought 449 AbbVie shares in Q3 2025, an estimated $91.4K.
AbbVie made up 1.12% of Lingohr Asset Management's portfolio in Q3 2025, its #36 holding.
Lingohr Asset Management first reported a position in AbbVie in Q2 2019 and has held it in 7 quarters since.
Lingohr Asset Management's AbbVie position peaked at $5.16M in Q1 2025.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Lingohr Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.